BCL6 and precursor B-cell acute lymphoblastic leukemia: Moreover, CX-4945 can increase Ikaros binding to the promoter of BCL6 and BACH2 (Data not shown), where it suppresses BCL6 (Figure 6C) and increases BACH2 expression (Figure 6D) in primary B-ALL.